<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37685544</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>17</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>The Potential Role of Hypothalamic Phospholipid Liposomes in the Supportive Therapy of Some Manifestations of Post-COVID-19 Condition: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Brain Fog.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5478</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12175478</ELocationID><Abstract><AbstractText>Post-COVID-19 condition (commonly known as Long COVID) is a heterogeneous clinical condition in which Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and brain fog stand out among the different clinical symptoms and syndromes. Cerebral metabolic alterations and neuroendocrine disorders seem to constitute an important part of the pathophysiology of Post-COVID-19 condition (PCC). Given the substantial lack of specific drugs and effective therapeutic strategies, hypothalamic phospholipid liposomes, which have been on the market for several years as adjuvant therapy for cerebral metabolic alterations resulting from neuroendocrine disorders, might represent a potential option in an overall therapeutic strategy that aims to control PCC-associated symptoms and syndromes. Their pharmacological mechanisms and clinical effects strongly support their potential effectiveness in PCC. Our initial clinical experience seems to corroborate this rationale. Further controlled clinical research is warranted in order to verify this hypothesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Menichetti</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Italian Group for Antimicrobial Stewardship (GISA), 27100 Pisa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">brain fog</Keyword><Keyword MajorTopicYN="N">chronic fatigue</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neuroendocrine disorders</Keyword><Keyword MajorTopicYN="N">phosphatidylserine</Keyword><Keyword MajorTopicYN="N">phospholipid liposome</Keyword><Keyword MajorTopicYN="N">phospholipids</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>9</Day><Hour>11</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>9</Day><Hour>11</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>9</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37685544</ArticleId><ArticleId IdType="pmc">PMC10488182</ArticleId><ArticleId IdType="doi">10.3390/jcm12175478</ArticleId><ArticleId IdType="pii">jcm12175478</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ministero della Salute  COVID-19&#x2014;Situazione in Italia.  [(accessed on 24 July 2023)]; Available online:  https://www.salute.gov.it/portale/nuovocoronavirus/dettaglioContenutiNuovoCoronavirus.jsp?area=nuovoCoronavirus&amp;id=5351&amp;lingua=italiano&amp;menu=vuoto.</Citation></Reference><Reference><Citation>Nurek M., Rayner C., Freyer A., Taylor S., J&#xe4;rte L., MacDermott N., Delaney B.C. Recommendations for the Recognition, Diagnosis, and Management of Long COVID: A Delphi Study. Br. J. Gen. Pract. 2021;71:e815&#x2013;e825. doi: 10.3399/BJGP.2021.0265.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2021.0265</ArticleId><ArticleId IdType="pmc">PMC8510689</ArticleId><ArticleId IdType="pubmed">34607799</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A Clinical Case Definition of Post-COVID-19 Condition by a Delphi Consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani D., Savale L., Noel N., Meyrignac O., Colle R., Gasnier M., Corruble E., Beurnier A., Jutant E.-M., Pham T., et al. Post-Acute COVID-19 Syndrome. Eur. Respir. Rev. 2022;31:210185. doi: 10.1183/16000617.0185-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0185-2021</ArticleId><ArticleId IdType="pmc">PMC8924706</ArticleId><ArticleId IdType="pubmed">35264409</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D., Moschopoulos C.D., Margalit I., Gkrania-Klotsas E., Landi F., Stahl J.-P., Yahav D. ESCMID Rapid Guidelines for Assessment and Management of Long COVID. Clin. Microbiol. Infect. 2022;28:955&#x2013;972. doi: 10.1016/j.cmi.2022.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Health and Human Services, Office of the Assistant Secretary for Health . National Research Action Plan on Long COVID. Department of Health and Human Services, Office of the Assistant Secretary for Health; Washington, DC, USA: 2022.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention  Post-COVID Conditions: Information for Healthcare Providers.  [(accessed on 10 July 2023)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.</Citation></Reference><Reference><Citation>Giuliano M., Tiple D., Agostoni P., Armocida B., Biardi L., Bonfigli A.R., Campana A., Ciardi M., Di Marco F., Floridia M., et al. Italian Good Practice Recommendations on Management of Persons with Long-COVID. Front. Public Health. 2023;11:1122141. doi: 10.3389/fpubh.2023.1122141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1122141</ArticleId><ArticleId IdType="pmc">PMC10157646</ArticleId><ArticleId IdType="pubmed">37151592</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodrow M., Carey C., Ziauddeen N., Thomas R., Akrami A., Lutje V., Greenwood D.C., Alwan N.A. Systematic Review of the Prevalence of Long COVID. Open Forum Infect. Dis. 2023;10:ofad233. doi: 10.1093/ofid/ofad233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad233</ArticleId><ArticleId IdType="pmc">PMC10316694</ArticleId><ArticleId IdType="pubmed">37404951</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and Risk Factors for Long COVID in Non-Hospitalized Adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam I.C.H., Wong C.K.H., Zhang R., Chui C.S.L., Lai F.T.T., Li X., Chan E.W.Y., Luo H., Zhang Q., Man K.K.C., et al. Long-Term Post-Acute Sequelae of COVID-19 Infection: A Retrospective, Multi-Database Cohort Study in Hong Kong and the UK. eClinicalMedicine. 2023;60:102000. doi: 10.1016/j.eclinm.2023.102000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102000</ArticleId><ArticleId IdType="pmc">PMC10173760</ArticleId><ArticleId IdType="pubmed">37197226</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., Sudry T., Flaks-Manov N., Yehezkelli Y., Kalkstein N., Akiva P., Ekka-Zohar A., Ben David S.S., Lerner U., Bivas-Benita M., et al. Long COVID Outcomes at One Year after Mild SARS-CoV-2 Infection: Nationwide Cohort Study. BMJ. 2023;380:e072529. doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T., Menges D., Anagnostopoulos A., Domenghino A., Aschmann H.E., Frei A., Fehr J.S., Puhan M.A. Recovery and Symptom Trajectories up to Two Years after SARS-CoV-2 Infection: Population Based, Longitudinal Cohort Study. BMJ. 2023;381:e074425. doi: 10.1136/bmj-2022-074425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-074425</ArticleId><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>National Center for Health Statistics  U.S. Census Bureau, Household Pulse Survey, 2022&#x2013;2023. Long COVID. Generated Interactively.  [(accessed on 12 July 2023)]; Available online:  https://www.cdc.gov/nchs/COVID19/pulse/long-COVID.htm.</Citation></Reference><Reference><Citation>Walker S., Goodfellow H., Pookarnjanamorakot P., Murray E., Bindman J., Blandford A., Bradbury K., Cooper B., Hamilton F.L., Hurst J.R., et al. Impact of Fatigue as the Primary Determinant of Functional Limitations among Patients with Post-COVID-19 Syndrome: A Cross-Sectional Observational Study. BMJ Open. 2023;13:e069217. doi: 10.1136/bmjopen-2022-069217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-069217</ArticleId><ArticleId IdType="pmc">PMC10335413</ArticleId><ArticleId IdType="pubmed">37286327</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major Findings, Mechanisms and Recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An Overview. Diabetes Metab. Syndr. Clin. Res. Rev. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffl H., Lang S.M. Long-Term Interplay between COVID-19 and Chronic Kidney Disease. Int. Urol. Nephrol. 2023;55:1977&#x2013;1984. doi: 10.1007/s11255-023-03528-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-023-03528-x</ArticleId><ArticleId IdType="pmc">PMC9955527</ArticleId><ArticleId IdType="pubmed">36828919</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L., Bested A.C., Bonilla H.F., Chheda B.V., Chu L., Curtin J.M., Dempsey T.T., Dimmock M.E., Dowell T.G., Felsenstein D., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. Mayo Clin. Proc. 2021;96:2861&#x2013;2878. doi: 10.1016/j.mayocp.2021.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos M.C., Nery T., Starke A.C., De Bem Alves A.C., Speck A.E., S Aguiar A. Post-Viral Fatigue in COVID-19: A Review of Symptom Assessment Methods, Mental, Cognitive, and Physical Impairment. Neurosci. Biobehav. Rev. 2022;142:104902. doi: 10.1016/j.neubiorev.2022.104902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2022.104902</ArticleId><ArticleId IdType="pmc">PMC9528075</ArticleId><ArticleId IdType="pubmed">36202253</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva O.A., Maksoud R., Beeraka N.M., Madhunapantula S.V., Sinelnikov M., Nikolenko V.N., Neganova M.E., Klochkov S.G., Amjad Kamal M., Staines D.R., et al. Analysis of Post COVID-19 Condition and Its Overlap with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Adv. Res. 2022;40:179&#x2013;196. doi: 10.1016/j.jare.2021.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType="pmc">PMC8619886</ArticleId><ArticleId IdType="pubmed">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Retornaz F., Rebaudet S., Stavris C., Jammes Y. Long-Term Neuromuscular Consequences of SARS-CoV-2 and Their Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Results of the Retrospective CoLGEM Study. J. Transl. Med. 2022;20:429. doi: 10.1186/s12967-022-03638-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03638-7</ArticleId><ArticleId IdType="pmc">PMC9509619</ArticleId><ArticleId IdType="pubmed">36153556</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens De Noordhout C., Primus-de Jong C., Cleemput I., Van Den Heede K. Pathophysiology and Mechanism of Long COVID: A Comprehensive Review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan M., Wang X., Gong M., Wang Q., Li Y., Jia J. Post-COVID Cognitive Dysfunction: Current Status and Research Recommendations for High Risk Population. Lancet Reg. Health-West. Pac. 2023;38:100836. doi: 10.1016/j.lanwpc.2023.100836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2023.100836</ArticleId><ArticleId IdType="pmc">PMC10344681</ArticleId><ArticleId IdType="pubmed">37457901</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The Immunology and Immunopathology of COVID-19. Science. 2022;375:1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai L., Kaiser R., Stark K. Thromboinflammation in Long COVID&#x2014;The Elusive Key to Postinfection Sequelae? J. Thromb. Haemost. 2023;21:2020&#x2013;2031. doi: 10.1016/j.jtha.2023.04.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2023.04.039</ArticleId><ArticleId IdType="pmc">PMC10174338</ArticleId><ArticleId IdType="pubmed">37178769</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodanovich M.Y., Kamaeva D.A., Naumova A.V. Role of Demyelination in the Persistence of Neurological and Mental Impairments after COVID-19. Int. J. Mol. Sci. 2022;23:11291. doi: 10.3390/ijms231911291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911291</ArticleId><ArticleId IdType="pmc">PMC9569975</ArticleId><ArticleId IdType="pubmed">36232592</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Laubscher G.J., Pretorius E. A Central Role for Amyloid Fibrin Microclots in Long COVID/PASC: Origins and Therapeutic Implications. Biochem. J. 2022;479:537&#x2013;559. doi: 10.1042/BCJ20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies M. Long COVID Patients Travel Abroad for Expensive and Experimental &#x201c;Blood Washing&#x201d;. BMJ. 2022;378:o1671. doi: 10.1136/bmj.o1671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1671</ArticleId><ArticleId IdType="pubmed">35820689</ArticleId></ArticleIdList></Reference><Reference><Citation>Auwaerter P.G. The Race to Understand Post&#x2013;COVID-19 Conditions. Ann. Intern. Med. 2021;174:1458&#x2013;1459. doi: 10.7326/M21-3072.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-3072</ArticleId><ArticleId IdType="pmc">PMC8565179</ArticleId><ArticleId IdType="pubmed">34461032</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Yu C., Jing H., Wu X., Novakovic V.A., Xie R., Shi J. Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation. Front. Cell. Infect. Microbiol. 2022;12:861703. doi: 10.3389/fcimb.2022.861703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrea L., Verde L., Grant W.B., Frias-Toral E., Sarno G., Vetrani C., Ceriani F., Garcia-Velasquez E., Contreras-Brice&#xf1;o J., Savastano S., et al. Vitamin D: A Role Also in Long COVID-19? Nutrients. 2022;14:1625. doi: 10.3390/nu14081625.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14081625</ArticleId><ArticleId IdType="pmc">PMC9028162</ArticleId><ArticleId IdType="pubmed">35458189</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrao S., Mallaci Bocchio R., Lo Monaco M., Natoli G., Cavezzi A., Troiani E., Argano C. Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc. Nutrients. 2021;13:1261. doi: 10.3390/nu13041261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13041261</ArticleId><ArticleId IdType="pmc">PMC8069903</ArticleId><ArticleId IdType="pubmed">33921297</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J., Liu X., Xiao W., Lu J., Guan L., Fang Z., Chen J., Sun B., Cai Z., Sun X., et al. Phospholipid Remodeling and Its Derivatives Are Associated with COVID-19 Severity. J. Allergy Clin. Immunol. 2023;151:1259&#x2013;1268. doi: 10.1016/j.jaci.2022.11.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2022.11.032</ArticleId><ArticleId IdType="pmc">PMC9891787</ArticleId><ArticleId IdType="pubmed">36736798</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x17d;arkovi&#x107; N., &#x141;uczaj W., Jarocka-Karpowicz I., Orehovec B., Bar&#x161;i&#x107; B., Tarle M., Kmet M., Luk&#x161;i&#x107; I., Biernacki M., Skrzydlewska E. Diversified Effects of COVID-19 as a Consequence of the Differential Metabolism of Phospholipids and Lipid Peroxidation Evaluated in the Plasma of Survivors and Deceased Patients upon Admission to the Hospital. Int. J. Mol. Sci. 2022;23:11810. doi: 10.3390/ijms231911810.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911810</ArticleId><ArticleId IdType="pmc">PMC9570244</ArticleId><ArticleId IdType="pubmed">36233111</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x17d;arkovi&#x107; N., Orehovec B., Bar&#x161;i&#x107; B., Tarle M., Kmet M., Luk&#x161;i&#x107; I., Tatzber F., Wonisch W., Skrzydlewska E., &#x141;uczaj W. Lipidomics Revealed Plasma Phospholipid Profile Differences between Deceased and Recovered COVID-19 Patients. Biomolecules. 2022;12:1488. doi: 10.3390/biom12101488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12101488</ArticleId><ArticleId IdType="pmc">PMC9599609</ArticleId><ArticleId IdType="pubmed">36291697</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurano M., Okamoto K., Jubishi D., Hashimoto H., Sakai E., Saigusa D., Kano K., Aoki J., Harada S., Okugawa S., et al. Dynamic Modulations of Sphingolipids and Glycerophospholipids in COVID-19. Clin. Transl. Med. 2022;12:e1069. doi: 10.1002/ctm2.1069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.1069</ArticleId><ArticleId IdType="pmc">PMC9549873</ArticleId><ArticleId IdType="pubmed">36214754</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur G., Ji X., Rahman I. SARS-CoV-2 Infection Alters Tryptophan Catabolism and Phospholipid Metabolism. Metabolites. 2021;11:659. doi: 10.3390/metabo11100659.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo11100659</ArticleId><ArticleId IdType="pmc">PMC8538244</ArticleId><ArticleId IdType="pubmed">34677374</ArticleId></ArticleIdList></Reference><Reference><Citation>Clough E., Inigo J., Chandra D., Chaves L., Reynolds J.L., Aalinkeel R., Schwartz S.A., Khmaladze A., Mahajan S.D. Mitochondrial Dynamics in SARS-CoV-2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID. J. Neuroimmune Pharmacol. 2021;16:770&#x2013;784. doi: 10.1007/s11481-021-10015-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-10015-6</ArticleId><ArticleId IdType="pmc">PMC8487226</ArticleId><ArticleId IdType="pubmed">34599743</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornick M.G., Olson M.E., Jadhav A.L. SARS-CoV-2 Psychiatric Sequelae: A Review of Neuroendocrine Mechanisms and Therapeutic Strategies. Int. J. Neuropsychopharmacol. 2022;25:1&#x2013;12. doi: 10.1093/ijnp/pyab069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ijnp/pyab069</ArticleId><ArticleId IdType="pmc">PMC8524640</ArticleId><ArticleId IdType="pubmed">34648616</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkazzaz M., Ahmed A., Abo-Amer Y.E.-E., Hydara T., Haikal A., Razek D.N.A.E., Eltayb W.A., Wang X., Karpi&#xb4;nski T.M., Hamza D., et al. In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19. Vaccines. 2022;10:1500. doi: 10.3390/vaccines10091500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10091500</ArticleId><ArticleId IdType="pmc">PMC9504287</ArticleId><ArticleId IdType="pubmed">36146578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammad R., Elshafei A., Khidr E.G., El-Husseiny A.A., Gomaa M.H., Kotb H.G., Eltrawy H.H., Farhoud H. Copeptin: A Neuroendocrine Biomarker of COVID-19 Severity. Biomark. Med. 2022;16:589&#x2013;597. doi: 10.2217/bmm-2021-1100.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm-2021-1100</ArticleId><ArticleId IdType="pmc">PMC8966690</ArticleId><ArticleId IdType="pubmed">35350852</ArticleId></ArticleIdList></Reference><Reference><Citation>Raony &#xcd;., De Figueiredo C.S., Pandolfo P., Giestal-de-Araujo E., Oliveira-Silva Bomfim P., Savino W. Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health. Front. Immunol. 2020;11:1170. doi: 10.3389/fimmu.2020.01170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01170</ArticleId><ArticleId IdType="pmc">PMC7267025</ArticleId><ArticleId IdType="pubmed">32574266</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensterle M., Herman R., Jane&#x17e; A., Mahmeed W.A., Al-Rasadi K., Al-Alawi K., Banach M., Banerjee Y., Ceriello A., Cesur M., et al. The Relationship between COVID-19 and Hypothalamic&#x2013;Pituitary&#x2013;Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess&#x2014;The CAPISCO International Expert Panel. Int. J. Mol. Sci. 2022;23:7326. doi: 10.3390/ijms23137326.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137326</ArticleId><ArticleId IdType="pmc">PMC9266848</ArticleId><ArticleId IdType="pubmed">35806331</ArticleId></ArticleIdList></Reference><Reference><Citation>Murga I., Aranburu L., Gargiulo P.A., G&#xf3;mez Esteban J.C., Lafuente J.-V. Clinical Heterogeneity in ME/CFS. A Way to Understand Long-COVID19 Fatigue. Front. Psychiatry. 2021;12:735784. doi: 10.3389/fpsyt.2021.735784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.735784</ArticleId><ArticleId IdType="pmc">PMC8542754</ArticleId><ArticleId IdType="pubmed">34707521</ArticleId></ArticleIdList></Reference><Reference><Citation>Noor N., Urits I., Degueure A., Rando L., Kata V., Cornett E.M., Kaye A.D., Imani F., Narimani-Zamanabadi M., Varrassi G., et al. A Comprehensive Update of the Current Understanding of Chronic Fatigue Syndrome. Anesth. Pain. Med. 2021;11:e113629. doi: 10.5812/aapm.113629.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/aapm.113629</ArticleId><ArticleId IdType="pmc">PMC8438707</ArticleId><ArticleId IdType="pubmed">34540633</ArticleId></ArticleIdList></Reference><Reference><Citation>Biggio G., Mostallino M.C., Giusti P., Zusso M., Toffano G. Overview of the Pharmacological Properties and Therapeutic Efficacy of Phospholipid Liposomes (Liposom Forte&#xae;) in Patients with Depressive Disorders. Minerva Psychiatry. 2018;59:45&#x2013;53. doi: 10.23736/S0391-1772.17.01955-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0391-1772.17.01955-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Biggio G., Mostallino M.C., Biggio F., Minervino A., Giannetti F. Therapeutic Efficacy and Tolerability of Phospholipid Liposomes (Liposom Forte&#xae;) for the Management of Depressive Disorders in Elderly Patients. Evid. Based Psychiatr. Care. 2020;6:76&#x2013;91. doi: 10.36180/2421-4469-2020-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.36180/2421-4469-2020-13</ArticleId></ArticleIdList></Reference><Reference><Citation>Nataf S. An Alteration of the Dopamine Synthetic Pathway Is Possibly Involved in the Pathophysiology of COVID-19. J. Med. Virol. 2020;92:1743&#x2013;1744. doi: 10.1002/jmv.25826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25826</ArticleId><ArticleId IdType="pmc">PMC7228370</ArticleId><ArticleId IdType="pubmed">32246784</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonini A., Leta V., Teo J., Chaudhuri K.R. Outcome of Parkinson&#x2019;s Disease Patients Affected by COVID-19. Mov. Disord. 2020;35:905&#x2013;908. doi: 10.1002/mds.28104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28104</ArticleId><ArticleId IdType="pmc">PMC7267273</ArticleId><ArticleId IdType="pubmed">32347572</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawlak R., Napiorkowska-Pawlak D., Takada Y., Urano T., Nagai N., Ihara H., Takada A. The Differential Effect of Angiotensin II and Angiotensin 1-7 on Norepinephrine, Epinephrine, and Dopamine Concentrations in Rat Hypothalamus: The Involvement of Angiotensin Receptors. Brain Res. Bull. 2001;54:689&#x2013;694. doi: 10.1016/S0361-9230(01)00489-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0361-9230(01)00489-0</ArticleId><ArticleId IdType="pubmed">11403997</ArticleId></ArticleIdList></Reference><Reference><Citation>Klempin F., Mosienko V., Matthes S., Villela D.C., Todiras M., Penninger J.M., Bader M., Santos R.A.S., Alenina N. Depletion of Angiotensin-Converting Enzyme 2 Reduces Brain Serotonin and Impairs the Running-Induced Neurogenic Response. Cell. Mol. Life Sci. 2018;75:3625&#x2013;3634. doi: 10.1007/s00018-018-2815-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2815-y</ArticleId><ArticleId IdType="pmc">PMC7079801</ArticleId><ArticleId IdType="pubmed">29679094</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Laksono B.M., De Vrij F.M.S., Kushner S.A., Harschnitz O., Van Riel D. The Neuroinvasiveness, Neurotropism, and Neurovirulence of SARS-CoV-2. Trends Neurosci. 2022;45:358&#x2013;368. doi: 10.1016/j.tins.2022.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8890977</ArticleId><ArticleId IdType="pubmed">35279295</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Zhu Q., Fox D.M., Gao C., Stanley S.A., Luo K. SARS-CoV-2 down-Regulates ACE2 through Lysosomal Degradation. MBoC. 2022;33:ar147. doi: 10.1091/mbc.E22-02-0045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E22-02-0045</ArticleId><ArticleId IdType="pmc">PMC9727799</ArticleId><ArticleId IdType="pubmed">36287912</ArticleId></ArticleIdList></Reference><Reference><Citation>Attademo L., Bernardini F. Are Dopamine and Serotonin Involved in COVID-19 Pathophysiology? Eur. J. Psychiatry. 2021;35:62&#x2013;63. doi: 10.1016/j.ejpsy.2020.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpsy.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7598536</ArticleId><ArticleId IdType="pubmed">33162632</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordeiro L.M.S., Rabelo P.C.R., Moraes M.M., Teixeira-Coelho F., Coimbra C.C., Wanner S.P., Soares D.D. Physical Exercise-Induced Fatigue: The Role of Serotonergic and Dopaminergic Systems. Braz. J. Med. Biol. Res. 2017;50:e6432. doi: 10.1590/1414-431x20176432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1414-431x20176432</ArticleId><ArticleId IdType="pmc">PMC5649871</ArticleId><ArticleId IdType="pubmed">29069229</ArticleId></ArticleIdList></Reference><Reference><Citation>Tornero-Aguilera J.F., Jimenez-Morcillo J., Rubio-Zarapuz A., Clemente-Su&#xe1;rez V.J. Central and Peripheral Fatigue in Physical Exercise Explained: A Narrative Review. Int. J. Environ. Res. Public Health. 2022;19:3909. doi: 10.3390/ijerph19073909.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19073909</ArticleId><ArticleId IdType="pmc">PMC8997532</ArticleId><ArticleId IdType="pubmed">35409591</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizzo M.C., Tegos S., Gallaminia A., Toffano G., Polleri A., Massarottib M. Brain Cortex Phospholipids Liposomes Effects on CSF HVA, 5-HIAA and on Prolactin and Somatotropin Secretion in Man. J. Neural Transm. 1978;43:93&#x2013;102. doi: 10.1007/BF01579068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01579068</ArticleId><ArticleId IdType="pubmed">731234</ArticleId></ArticleIdList></Reference><Reference><Citation>Toffano G., Bruni A. Pharmacological Properties of Phospholipid Liposomes. Pharmacol. Res. Commun. 1980;12:829&#x2013;845. doi: 10.1016/S0031-6989(80)80046-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0031-6989(80)80046-4</ArticleId><ArticleId IdType="pubmed">6108574</ArticleId></ArticleIdList></Reference><Reference><Citation>Canonico P.L., Annunziato L., Toffano G., Bernardini R., Stanzani S., Foti M., Clementi G., Drago F., Scapagnini U. In Vivo and in Vitro Interference of Phosphatidylserine Liposomes on Prolactin Secretion in the Rat. Neuroendocrinology. 1981;33:358&#x2013;362. doi: 10.1159/000123261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000123261</ArticleId><ArticleId IdType="pubmed">7198720</ArticleId></ArticleIdList></Reference><Reference><Citation>Inukai S., Hara S., Ichinose H. Tyrosine Hydroxylase Activity Is Regulated through the Modification of the 176th Cysteine Residue. Biochem. Biophys. Res. Commun. 2022;589:209&#x2013;214. doi: 10.1016/j.bbrc.2021.12.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.12.024</ArticleId><ArticleId IdType="pubmed">34922205</ArticleId></ArticleIdList></Reference><Reference><Citation>Soung A.L., Vanderheiden A., Nordvig A.S., Sissoko C.A., Canoll P., Mariani M.B., Jiang X., Bricker T., Rosoklija G.B., Arango V., et al. COVID-19 Induces CNS Cytokine Expression and Loss of Hippocampal Neurogenesis. Brain. 2022;145:4193&#x2013;4201. doi: 10.1093/brain/awac270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac270</ArticleId><ArticleId IdType="pmc">PMC9452175</ArticleId><ArticleId IdType="pubmed">36004663</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A., Shah M., Ahmad S.A., Premraj L., Wildi K., Li Bassi G., Pardo C.A., Choi A., Cho S.-M. Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. Cells. 2023;12:816. doi: 10.3390/cells12050816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050816</ArticleId><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., Lu P., Geraghty A.C., Song E., Lee M.-H., Wood J., O&#x2019;Dea M.R., Dutton S., Shamardani K., Nwangwu K., et al. Mild Respiratory COVID Can Cause Multi-Lineage Neural Cell and Myelin Dysregulation. Cell. 2022;185:2452&#x2013;2468. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes-V&#xe9;lez J.A., Aksoy Yasar F.B., Hu J. Myelin Lipid Metabolism and Its Role in Myelination and Myelin Maintenance. The Innovation. 2023;4:100360. doi: 10.1016/j.xinn.2022.100360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xinn.2022.100360</ArticleId><ArticleId IdType="pmc">PMC9800635</ArticleId><ArticleId IdType="pubmed">36588745</ArticleId></ArticleIdList></Reference><Reference><Citation>Fledrich R., Abdelaal T., Rasch L., Bansal V., Sch&#xfc;tza V., Br&#xfc;gger B., L&#xfc;chtenborg C., Prukop T., Stenzel J., Rahman R.U., et al. Targeting Myelin Lipid Metabolism as a Potential Therapeutic Strategy in a Model of CMT1A Neuropathy. Nat. Commun. 2018;9:3025. doi: 10.1038/s41467-018-05420-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05420-0</ArticleId><ArticleId IdType="pmc">PMC6072747</ArticleId><ArticleId IdType="pubmed">30072689</ArticleId></ArticleIdList></Reference><Reference><Citation>Monastra G., Cross A.H., Bruni A., Raine C.S. Phosphatidylserine, a Putative Inhibitor of Tumor Necrosis Factor, Prevents Autoimmune Demyelination. Pt 1Neurology. 1993;43:153. doi: 10.1212/WNL.43.1_Part_1.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.43.1_Part_1.153</ArticleId><ArticleId IdType="pubmed">8423880</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi-Galougahi M., Yousefi-Koma A., Bakhshayeshkaram M., Raad N., Haseli S. 18FDG PET/CT Scan Reveals Hypoactive Orbitofrontal Cortex in Anosmia of COVID-19. Acad. Radiol. 2020;27:1042&#x2013;1043. doi: 10.1016/j.acra.2020.04.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acra.2020.04.030</ArticleId><ArticleId IdType="pmc">PMC7196385</ArticleId><ArticleId IdType="pubmed">32386948</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Morbelli S., Ciccarelli M., Cecconi M., Aghemo A., Morelli P., Chiola S., Gelardi F., Chiti A. Long COVID Hallmarks on [18F]FDG-PET/CT: A Case-Control Study. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:3187&#x2013;3197. doi: 10.1007/s00259-021-05294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05294-3</ArticleId><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., Guis S., Barthelemy F., Habert P., Ceccaldi M., et al. 18F-FDG Brain PET Hypometabolism in Patients with Long COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Donegani M.I., Miceli A., Pardini M., Bauckneht M., Chiola S., Pennone M., Marini C., Massa F., Raffa S., Ferrarazzo G., et al. Brain Metabolic Correlates of Persistent Olfactory Dysfunction after SARS-CoV-2 Infection. Biomedicines. 2021;9:287. doi: 10.3390/biomedicines9030287.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9030287</ArticleId><ArticleId IdType="pmc">PMC7998481</ArticleId><ArticleId IdType="pubmed">33808956</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T., Workman C.D., Ponto L.L.B. 18F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations. Viruses. 2021;13:2283. doi: 10.3390/v13112283.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13112283</ArticleId><ArticleId IdType="pmc">PMC8625263</ArticleId><ArticleId IdType="pubmed">34835088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R., Cuffaro L., Capozza A., Rosci C., Maiorana N., Groppo E., Reitano M.R., Poletti B., Ticozzi N., Tagliabue L., et al. Brain Positron Emission Tomography (PET) and Cognitive Abnormalities One Year after COVID-19. J. Neurol. 2023;270:1823&#x2013;1834. doi: 10.1007/s00415-022-11543-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11543-8</ArticleId><ArticleId IdType="pmc">PMC9873215</ArticleId><ArticleId IdType="pubmed">36692636</ArticleId></ArticleIdList></Reference><Reference><Citation>Salonia A., Pontillo M., Capogrosso P., Pozzi E., Ferrara A.M., Cotelessa A., Belladelli F., Corsini C., Gregori S., Rowe I., et al. Testosterone in Males with COVID-19: A 12-month Cohort Study. Andrology. 2023;11:17&#x2013;23. doi: 10.1111/andr.13322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.13322</ArticleId><ArticleId IdType="pmc">PMC9874525</ArticleId><ArticleId IdType="pubmed">36251583</ArticleId></ArticleIdList></Reference><Reference><Citation>Uckert S., Fuhlenriede M.H., Becker A.J., Stief C.G., Scheller F., Knapp W.H., Jonas U. Is There an Inhibitory Role of Cortisol in the Mechanism of Male Sexual Arousal and Penile Erection? Urol. Res. 2003;31:402&#x2013;406. doi: 10.1007/s00240-003-0359-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00240-003-0359-5</ArticleId><ArticleId IdType="pubmed">14508617</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvio G., Martino M., Giancola G., Arnaldi G., Balercia G. Hypothalamic&#x2013;Pituitary Diseases and Erectile Dysfunction. J. Clin. Med. 2021;10:2551. doi: 10.3390/jcm10122551.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10122551</ArticleId><ArticleId IdType="pmc">PMC8229897</ArticleId><ArticleId IdType="pubmed">34207687</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeyemi D.H., Odetayo A.F., Hamed M.A., Akhigbe R.E. Impact of COVID 19 on Erectile Function. Aging Male. 2022;25:202&#x2013;216. doi: 10.1080/13685538.2022.2104833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13685538.2022.2104833</ArticleId><ArticleId IdType="pubmed">35924485</ArticleId></ArticleIdList></Reference><Reference><Citation>Leema Rose A., Manickam A., Agrawal M. A Mathematical Model for The Special Effects of Phosphatidylserine on Endocrine Reaction to Reasonable Concentration Exercise in Healthy Male Subjects. Turk. J. Comput. Math. Educ. 2021;12:3555&#x2013;3559. doi: 10.17762/turcomat.v12i3.1632.</Citation><ArticleIdList><ArticleId IdType="doi">10.17762/turcomat.v12i3.1632</ArticleId></ArticleIdList></Reference><Reference><Citation>Starks M.A., Starks S.L., Kingsley M., Purpura M., J&#xe4;ger R. The Effects of Phosphatidylserine on Endocrine Response to Moderate Intensity Exercise. J. Int. Soc. Sports Nutr. 2008;5:11. doi: 10.1186/1550-2783-5-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1550-2783-5-11</ArticleId><ArticleId IdType="pmc">PMC2503954</ArticleId><ArticleId IdType="pubmed">18662395</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiriakova N., Kiriakov A., Schneider E., Bonev A. Therapeutic Effect of Essential Phospholipids on Functional Sexual Disorders in Males. J. Eur. Acad. Dermatol. Venerol. 1998;11:191&#x2013;193. doi: 10.1111/j.1468-3083.1998.tb00783.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-3083.1998.tb00783.x</ArticleId><ArticleId IdType="pubmed">9784056</ArticleId></ArticleIdList></Reference><Reference><Citation>Casacchia M., Marola W., Meco G., Pirro R., Di Cesare E., Allegro A., Cusimano G. Phospholipid Liposomes in Depression: A Double-Blind Study versus Placebo. Int. Pharmacopsychiatry. 1982;17:274&#x2013;279. doi: 10.1159/000468583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000468583</ArticleId><ArticleId IdType="pubmed">7185771</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguglia E., Calandra C., Rapisarda V., Maugeri D. The Effect of Hypothalamic Phospholipid Liposomes in Patients Treated with Sulpiride or Haloperidol. Acta Ther. 1984;10:133&#x2013;144.</Citation></Reference><Reference><Citation>Giannelli A., Rabboni M., Zarattini F., Malgeri C., Magnolfi G. A Combination of Hypothalamic Phospholipid Liposomes with Trazodone for Treatment of Depression.: An Open Controlled Study. Acta Psychiatr. Scand. 1989;79:52&#x2013;58. doi: 10.1111/j.1600-0447.1989.tb09234.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1989.tb09234.x</ArticleId><ArticleId IdType="pubmed">2648767</ArticleId></ArticleIdList></Reference><Reference><Citation>Rachev E., Nalbansky B., Kolarov G., Agros&#xec; M. Efficacy and Safety of Phospholipid Liposomes in the Treatment of Neuropsychological Disorders Associated with the Menopause: A Double-Blind, Randomised, Placebo-Controlled Study. Curr. Med. Res. Opin. 2001;17:105&#x2013;110. doi: 10.1185/030079901317010748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/030079901317010748</ArticleId><ArticleId IdType="pubmed">11759177</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruni A., Toffano G., Leon A., Boarato E. Pharmacological Effects of Phosphatidylserine Liposomes. Nature. 1976;260:331&#x2013;333. doi: 10.1038/260331a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/260331a0</ArticleId><ArticleId IdType="pubmed">1256571</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang E.Y., Cui F., Kim H.K., Nawaz H., Kang S., Kim H., Jang J., Go G. Effect of Phosphatidylserine on Cognitive Function in the Elderly: A Systematic Review and Meta-Analysis. Korean J. Food Sci. Technol. 2022;54:52&#x2013;58. doi: 10.9721/KJFST.2022.54.1.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.9721/KJFST.2022.54.1.52</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug Administration  Letter Updating the Phosphatidylserine and Cognitive Function and Dementia Qualified Health Claim, 2004.  [(accessed on 6 June 2023)]; Available online:  http://wayback.archive-it.org/7993/20171114183737/https://www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm072999.htm.</Citation></Reference><Reference><Citation>Zhang Y.Y., Yang L.Q., Guo L.M. Effect of Phosphatidylserine on Memory in Patients and Rats with Alzheimer&#x2019;s Disease. Genet. Mol. Res. 2015;14:9325&#x2013;9333. doi: 10.4238/2015.August.10.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.4238/2015.August.10.13</ArticleId><ArticleId IdType="pubmed">26345866</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J., S&#xe1;ez-Franc&#xe0;s N., Santillo D., Alegre J. Treatment and Management of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: All Roads Lead to Rome: Therapy and Management in CFS/ME. Br. J. Pharmacol. 2017;174:345&#x2013;369. doi: 10.1111/bph.13702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13702</ArticleId><ArticleId IdType="pmc">PMC5301046</ArticleId><ArticleId IdType="pubmed">28052319</ArticleId></ArticleIdList></Reference><Reference><Citation>Licata G. Hypothalamic phospholipid liposomes. A drug for the treatment of anxiety-depressive syndromes in internal medicine. Recent. Prog. Med. 1984;75:1076&#x2013;1080.</Citation><ArticleIdList><ArticleId IdType="pubmed">6528083</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff Sagy Y., Feldhamer I., Brammli-Greenberg S., Lavie G. Estimating the Economic Burden of Long-COVID: The Additive Cost of Healthcare Utilisation among COVID-19 Recoverees in Israel. BMJ Glob. Health. 2023;8:e012588. doi: 10.1136/bmjgh-2023-012588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2023-012588</ArticleId><ArticleId IdType="pmc">PMC10357303</ArticleId><ArticleId IdType="pubmed">37463787</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>